Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 32.65
0.00 (0.00%)
At close: Oct 16, 2026
Anya Biopharm Market Cap
Anya Biopharm has a market cap or net worth of 1.6 billion as of October 16, 2026. It is the 30,369th most valuable company in the world and the 1,795th biggest in Taiwan. Its market cap has decreased by 35.22% in one year.
Market Cap
1.60B
Enterprise Value
1.29B
Revenue
13.06M
Global Rank
Country Rank
#1,795 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 25, 2024, Anya Biopharm's market cap has decreased from 2.85B to 1.60B, a decrease of -43.80%. That is a compound annual growth rate of -25.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.60B | -31.69% |
| Dec 31, 2025 | 2.35B | 26.96% |
| Dec 31, 2024 | 1.85B | -35.20% |
| Oct 25, 2024 | 2.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taho Pharmaceuticals | 11.56B |
| Pharmasaga | 8.43B |
| Protect Animal Health | 2.71B |
| TEH SENG Pharmaceutical Mfg. | 2.45B |
| Libo Pharma | 2.22B |
| Anbogen Therapeutics | 1.93B |
| Gin Hwa Biotech Incorporation | 1.81B |
| Timing Pharmaceutial | 1.73B |